Battery Recycling Market
Description
Battery Recycling Market Summary
The global battery recycling market size was estimated at USD 3.41 billion in 2025 and is projected to reach USD 43.47 billion by 2033, growing at a CAGR of 37.7% from 2026 to 2033. Industry growth is primarily driven by the rapid expansion of electric vehicles, renewable energy storage systems, and consumer electronics, which are significantly increasing the volume of end-of-life batteries.
Stringent environmental regulations on battery disposal, extended producer responsibility (EPR) frameworks, and government mandates promoting sustainable waste management are compelling manufacturers and recyclers to invest in advanced recycling infrastructure. Additionally, rising concerns over supply chain security for critical raw materials such as lithium, cobalt, nickel, and lead are accelerating recycling adoption as a strategic alternative to primary mining.
Technological advancements in hydrometallurgical and direct recycling processes are improving recovery rates, cost efficiency, and material purity, making recycled battery materials increasingly competitive with virgin sources. Governments across North America, Europe, and the Asia-Pacific are supporting the market through subsidies, recycling targets, and policies aligned with circular economy and decarbonization goals. Growing collaborations between battery manufacturers, automotive OEMs, and recycling companies are further strengthening closed-loop supply chains, positioning battery recycling as a critical pillar of the global clean energy and electric mobility ecosystem.
Global Battery Recycling Market Report Segmentation
This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global battery recycling market report on the basis of source, battery type, recycling method, and region.
The global battery recycling market size was estimated at USD 3.41 billion in 2025 and is projected to reach USD 43.47 billion by 2033, growing at a CAGR of 37.7% from 2026 to 2033. Industry growth is primarily driven by the rapid expansion of electric vehicles, renewable energy storage systems, and consumer electronics, which are significantly increasing the volume of end-of-life batteries.
Stringent environmental regulations on battery disposal, extended producer responsibility (EPR) frameworks, and government mandates promoting sustainable waste management are compelling manufacturers and recyclers to invest in advanced recycling infrastructure. Additionally, rising concerns over supply chain security for critical raw materials such as lithium, cobalt, nickel, and lead are accelerating recycling adoption as a strategic alternative to primary mining.
Technological advancements in hydrometallurgical and direct recycling processes are improving recovery rates, cost efficiency, and material purity, making recycled battery materials increasingly competitive with virgin sources. Governments across North America, Europe, and the Asia-Pacific are supporting the market through subsidies, recycling targets, and policies aligned with circular economy and decarbonization goals. Growing collaborations between battery manufacturers, automotive OEMs, and recycling companies are further strengthening closed-loop supply chains, positioning battery recycling as a critical pillar of the global clean energy and electric mobility ecosystem.
Global Battery Recycling Market Report Segmentation
This report forecasts volume & revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global battery recycling market report on the basis of source, battery type, recycling method, and region.
- Source Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
- Manufacturing Scrap
- Automotive
- Consumer Electronics
- Others
- Battery Type Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
- Lead-Acid
- Lithium-ion
- Nickel
- Others
- Recycling Method Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
- Pyrometallurgy
- Hydrometallurgy
- Direct Recycling
- Others
- Regional Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Norway
- Poland
- Asia Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.2 Segment Definitions
- 1.2.1 Drug Class
- 1.2.2 Application
- 1.2.3 Route of Administration
- 1.3 Estimates and Forecast Timeline
- 1.4 Research Methodology
- 1.5 Information Procurement
- 1.5.1 Purchased Database
- 1.5.2 GVR’s Internal Database
- 1.5.3 Secondary Sources
- 1.5.4 Primary Research
- 1.6 Information Analysis
- 1.6.1 Data Analysis Models
- 1.7 Market Formulation & Data Visualization
- 1.8 Model Details
- 1.8.1 Commodity Flow Analysis
- 1.9 List of Secondary Sources
- 1.10 Objectives
- Chapter 2. Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape Snapshot
- Chapter 3 Branded Generics Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.2 Market Restraint Analysis
- 3.3 Business Environment Analysis
- 3.3.1 Industry Analysis - Porter’s Five Forces Analysis
- 3.3.1.1 Supplier Power
- 3.3.1.2 Buyer Power
- 3.3.1.3 Substitution Threat
- 3.3.1.4 Threat of New Entrants
- 3.3.1.5 Competitive Rivalry
- 3.3.2 PESTLE Analysis
- 3.3.3 Pipeline Analysis
- 3.3.4 Patent Expiry Analysis
- 3.3.5 Pricing Analysis
- Chapter 4. Branded Generics Market: Drug Class Business Analysis
- 4.1. Drug Class Market Share, 2025 & 2033
- 4.2. Drug Class Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
- 4.4. Alkylating Agents
- 4.4.1 Alkylating Agents Market, 2021 - 2033 (USD Million)
- 4.5. Antimetabolites
- 4.5.1 Antimetabolites Market, 2021 - 2033 (USD Million)
- 4.6. Hormones
- 4.6.1 Hormones Market, 2021 - 2033 (USD Million)
- 4.7. Anti-hypertensive
- 4.7.1 Anti-hypertensive Market, 2021 - 2033 (USD Million)
- 4.8. Lipid Lowering drugs
- 4.8.1 Lipid Lowering drugs Market, 2021 - 2033 (USD Million)
- 4.9. Anti-depressants
- 4.9.1 Anti-depressants Market, 2021 - 2033 (USD Million)
- 4.10. Anti-psychotics
- 4.10.1 Anti-psychotics Market, 2021 - 2033 (USD Million)
- 4.11. Anti-epileptics
- 4.11.1 Anti-epileptics Market, 2021 - 2033 (USD Million)
- 4.12. Others
- 4.12.1 Others Market, 2021 - 2033 (USD Million)
- Chapter 5. Branded Generics Market: Application Business Analysis
- 5.1. Application Market Share, 2025 & 2033
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Oncology
- 5.4.1 Oncology Market, 2021 - 2033 (USD Million)
- 5.5. Cardiovascular Diseases
- 5.5.1 Cardiovascular Diseases Market, 2021 - 2033 (USD Million)
- 5.6. Neurological Diseases
- 5.6.1 Neurological Diseases Market, 2021 - 2033 (USD Million)
- 5.7. Gastrointestinal Diseases
- 5.7.1 Gastrointestinal Diseases Market, 2021 - 2033 (USD Million)
- 5.8. Dermatological diseases
- 5.8.1 Dermatological diseases Market, 2021 - 2033 (USD Million)
- 5.9. Acute and Chronic Pain
- 5.9.1 Acute and Chronic Pain Market, 2021 - 2033 (USD Million)
- 5.10. Others
- 5.10.1 Others Market, 2021 - 2033 (USD Million)
- Chapter 6. Branded Generics Market: Route of Administration Business Analysis
- 6.1. Route of Administration Market Share, 2025 & 2033
- 6.2. Route of Administration Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
- 6.4. Oral
- 6.4.1 Oral Market, 2021 - 2033 (USD Million)
- 6.5. Topical
- 6.5.1 Topical Market, 2021 - 2033 (USD Million)
- 6.4. Parenteral
- 6.4.1 Parenteral Market, 2021 - 2033 (USD Million)
- 6.5. Others
- 6.5.1 Others Market, 2021 - 2033 (USD Million)
- Chapter 7. Branded Generics Market: Distribution Channel Business Analysis
- 7.1. Distribution Channel Market Share, 2025 & 2033
- 7.2. Distribution Channel Segment Dashboard
- 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
- 7.4. Hospital Pharmacy
- 7.4.1 Hospital Pharmacy Market, 2021 - 2033 (USD Million)
- 7.5. Retail Pharmacy
- 7.5.1 Retail Pharmacy Market, 2021 - 2033 (USD Million)
- 7.6. Online Pharmacy & Others
- 7.6.1 Online Pharmacy & Others Market, 2021 - 2033 (USD Million)
- Chapter 8. Branded Generics Market: Regional Estimates & Trend Analysis
- 8.1 Regional Market Share Analysis, 2025 & 2033
- 8.2 Regional Market Dashboard
- 8.3 Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 8.4 North America
- 8.4.1 North America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.4.2 U.S.
- 8.4.2.1 Key Country Dynamics
- 8.4.2.2 Regulatory Framework
- 8.4.2.3 Pricing Analysis
- 8.4.2.4 U.S. Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.3 Canada
- 8.4.3.1 Key Country Dynamics
- 8.4.3.2 Regulatory Framework
- 8.4.3.3 Pricing Analysis
- 8.4.3.4 Canada Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.4.4 Mexico
- 8.4.4.1 Key Country Dynamics
- 8.4.4.2 Regulatory Framework
- 8.4.4.3 Pricing Analysis
- 8.4.4.4 Mexico Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5 Europe
- 8.5.1 Europe Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.5.2 UK
- 8.5.2.1 Key Country Dynamics
- 8.5.2.2 Regulatory Framework
- 8.5.2.3 Pricing Analysis
- 8.5.2.4 UK Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.3 Germany
- 8.5.3.1 Key Country Dynamics
- 8.5.3.2 Regulatory Framework
- 8.5.3.3 Pricing Analysis
- 8.5.3.4 Germany Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.4 France
- 8.5.4.1 Key Country Dynamics
- 8.5.4.2 Regulatory Framework
- 8.5.4.3 Pricing Analysis
- 8.5.4.4 France Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.5 Italy
- 8.5.5.1 Key Country Dynamics
- 8.5.5.2 Regulatory Framework
- 8.5.5.3 Pricing Analysis
- 8.5.5.4 Italy Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.6 Spain
- 8.5.6.1 Key Country Dynamics
- 8.5.6.2 Regulatory Framework
- 8.5.6.3 Pricing Analysis
- 8.5.6.4 Spain Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.7 Denmark
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Denmark Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.8 Norway
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Norway Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.5.9 Sweden
- 8.5.8.1 Key Country Dynamics
- 8.5.8.2 Regulatory Framework
- 8.5.8.3 Pricing Analysis
- 8.5.8.4 Sweden Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6 Asia Pacific
- 8.6.1 Asia Pacific Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.6.2 Japan
- 8.6.2.1 Key Country Dynamics
- 8.6.2.2 Regulatory Framework
- 8.6.2.3 Pricing Analysis
- 8.6.2.4 Japan Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.3 China
- 8.6.3.1 Key Country Dynamics
- 8.6.3.2 Regulatory Framework
- 8.6.3.3 Pricing Analysis
- 8.6.3.4 China Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.4 India
- 8.6.4.1 Key Country Dynamics
- 8.6.4.2 Regulatory Framework
- 8.6.4.3 Pricing Analysis
- 8.6.4.4 India Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.5 South Korea
- 8.6.5.1 Key Country Dynamics
- 8.6.5.2 Regulatory Framework
- 8.6.5.3 Pricing Analysis
- 8.6.5.4 South Korea Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.6 Australia
- 8.6.6.1 Key Country Dynamics
- 8.6.6.2 Regulatory Framework
- 8.6.6.3 Pricing Analysis
- 8.6.6.4 Australia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.6.7 Thailand
- 8.6.8.1 Key Country Dynamics
- 8.6.8.2 Regulatory Framework
- 8.6.8.3 Pricing Analysis
- 8.6.8.4 Thailand Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.7 Latin America
- 8.8.1 Latin America Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 Brazil
- 8.8.2.1 Key Country Dynamics
- 8.8.2.2 Regulatory Framework
- 8.8.2.3 Pricing Analysis
- 8.8.2.4 Brazil Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Argentina
- 8.8.3.1 Key Country Dynamics
- 8.8.3.2 Regulatory Framework
- 8.8.3.3 Pricing Analysis
- 8.8.3.4 Argentina Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8 Middle East & Africa
- 8.8.1 Middle East & Africa Branded Generics Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 8.8.2 South Africa
- 8.8.2.1 Key Country Dynamics
- 8.8.2.2 Regulatory Framework
- 8.8.2.3 Pricing Analysis
- 8.8.2.4 South Africa Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.3 Saudi Arabia
- 8.8.3.1 Key Country Dynamics
- 8.8.3.2 Regulatory Framework
- 8.8.3.3 Pricing Analysis
- 8.8.3.4 Saudi Arabia Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.4 UAE
- 8.8.4.1 Key Country Dynamics
- 8.8.4.2 Regulatory Framework
- 8.8.4.3 Pricing Analysis
- 8.8.4.4 UAE Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 8.8.5 Kuwait
- 8.8.5.1 Key Country Dynamics
- 8.8.5.2 Regulatory Framework
- 8.8.5.3 Pricing Analysis
- 8.8.5.4 Kuwait Branded Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Participant Overview
- 9.2. Company Market Position Analysis
- 9.3. Company Categorization
- 9.4. Strategy Mapping
- 9.5. Company Profiles/Listing
- 9.5.1 Sun Pharmaceutical Industries Ltd.
- 9.5.1.1 Overview
- 9.5.1.2 Financial Performance
- 9.5.1.3 Product Benchmarking
- 9.5.1.4 Strategic Initiatives
- 9.5.2 Teva Pharmaceutical Industries Ltd.
- 9.5.2.1 Overview
- 9.5.2.2 Financial Performance
- 9.5.2.3 Product Benchmarking
- 9.5.2.4 Strategic Initiatives
- 9.5.3 Cipla Ltd.
- 9.5.3.1 Overview
- 9.5.3.2 Financial Performance
- 9.5.3.3 Product Benchmarking
- 9.5.3.4 Strategic Initiatives
- 9.5.4 Dr. Reddy’s Laboratories Ltd.
- 9.5.4.1 Overview
- 9.5.4.2 Financial Performance
- 9.5.4.3 Product Benchmarking
- 9.5.4.4 Strategic Initiatives
- 9.5.5 Lupin Ltd.
- 9.5.5.1 Overview
- 9.5.5.2 Financial Performance
- 9.5.5.3 Product Benchmarking
- 9.5.5.4 Strategic Initiatives
- 9.5.6 Aurobindo Pharma Ltd.
- 9.5.6.1 Overview
- 9.5.6.2 Financial Performance
- 9.5.6.3 Product Benchmarking
- 9.5.6.4 Strategic Initiatives
- 9.5.7 Torrent Pharmaceuticals Ltd.
- 9.5.7.1 Overview
- 9.5.7.2 Financial Performance
- 9.5.7.3 Product Benchmarking
- 9.5.7.4 Strategic Initiatives
- 9.5.8 Viatris Inc.
- 9.5.9.1 Overview
- 9.5.9.2 Financial Performance
- 9.5.9.3 Product Benchmarking
- 9.5.9.4 Strategic Initiatives
- 9.5.9 Sanofi
- 9.5.7.1 Overview
- 9.5.7.2 Financial Performance
- 9.5.7.3 Product Benchmarking
- 9.5.7.4 Strategic Initiatives
- 9.5.10 Abbott
- 9.5.8.1 Overview
- 9.5.8.2 Financial Performance
- 9.5.8.3 Product Benchmarking
- 9.5.8.4 Strategic Initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
